Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Sep 28:9:711616.
doi: 10.3389/fpubh.2021.711616. eCollection 2021.

COVID-19: Pulmonary and Extra Pulmonary Manifestations

Islam H Elrobaa  1 , Karl J New  2
Affiliations
Review

COVID-19: Pulmonary and Extra Pulmonary Manifestations

Islam H Elrobaa et al. Front Public Health. .

Abstract

Introduction: The coronavirus disease-2019 (COVID-19) pandemic has been the most significant event in 2020, with ~86.8 million cases and 1.88 million deaths worldwide. It is a highly infectious disease, wherein the virus (severe acute respiratory syndrome coronavirus 2) rapidly multiplies and spreads to all parts of the body. Therefore, COVID-19 is not only respiratory disease but also a multisystem disease. Many people, including physicians, incorrectly believe that the disease affects only the respiratory tract. In this study, we aimed to describe COVID-19 manifestations and the underlying pathophysiology to provide the readers with a better understanding of this disease to achieve good management and to control the spread of this disease. Methods: Secondary data were obtained from PubMed, Google Scholar, and Scopus databases. The keywords used for the search were as follows: COVID-19, COVID-19 pulmonary manifestations, COVID-19 extra pulmonary manifestations, and pathophysiology of COVID-19. We collected secondary data from systemic reviews, metaanalyses, case series, and case reports in the form of public data that was published on websites of the government, medical corporations, medical peer-reviewed journals, and medical academies, all of which were indexed in PubMed, Google Scholar, or Scopus. Our questions were as follows: Is COVID-19 a respiratory disease only? and What are the extrapulmonary manifestations of COVID-19? Results: From our data, we found that a patient with COVID-19 may be either asymptomatic or symptomatic. Symptomatic cases may have either pulmonary or extrapulmonary manifestations. Pulmonary manifestations occur as mild, moderate, or severe cases. In mild and moderate cases, extrapulmonary manifestations such as gastroenteritis, fever, or vomiting may present alone. Some of these cases may be missed for diagnosis, and the patient may receive symptomatic treatment without a COVID-19 diagnosis, leading to increased spread of the infection. Extrapulmonary manifestations may occur in severe and critical cases as complications of severe infections (high viral overload) or the cytokine storm, such as in acute kidney injury (AKI), heart failure (HF), and venous thromboembolic (VTE) manifestation. Conclusion: COVID-19 is not a respiratory disease alone; rather, it is a multisystem disease. Pulmonary and extrapulmonary manifestations should be considered for early diagnosis and to control the spread of the infection.

Keywords: COVID-19; extra pulmonary; infection control; manifestations; pulmonary.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
Diagram to explain the presentation of extrapulmonary manifestations of COVID-19.
Figure 2
Figure 2
Diagram to explain the COVID-19 presentations in Health care provider centres.
Figure 3
Figure 3
Diagram to explain Cytokine storm effect in COVID-19 patient.
Figure 4
Figure 4
Blood values in COVID-19 patients (high severe and critical cases).
See this image and copyright information in PMC

References

    1. World Health Organization . Director-General's Remarks at the Media Briefing on 2019-nCoV on 11 February 2020 2020). Available online at: https://www.who.int/dg/speeches/detail/who-director-general-s-remarks-at... (accessed February 12, 2020).
    1. World Health Organization . Novel Coronavirus (2019-nCoV) Technical Guidance (2020). Available online at: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/technica... (accessed Feburary 14, 2020).
    1. Bajema KL, Oster AM, McGovern OL, Stenger MR, Anderson TC, Cheryl Isenhour DVM, et al. Persons Evaluated for 2019 Novel Coronavirus - United States. MMWR. MMWMorbidity R and Mortality Weekly Report; (2020). - PMC - PubMed
    1. Chan JF, Yuan S, Kok KH, To KK, Chu H, Yang J, et al. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. Lancet. (2020) 395:514–523. 10.1016/S0140-6736(20)30154-9 - DOI - PMC - PubMed
    1. Yang X, Yu Y, Xu J, Shu H, Xia J, Liu H, et al. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Respir Med. (2020) 8:475–81. 10.1016/S2213-2600(20)30079-5 - DOI - PMC - PubMed